Market Cap

Natera, Inc. Market Capitalization:

$31.91 Billion

USD as of Jan. 1, 2026

business Natera, Inc. Company Profile

Natera, Inc. Main Stock Listing

NASDAQ: NTRA

Market Capitalization History of Natera, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $222.61 B
Danaher $164.98 B
Siemens Healthineers AG $57.84 B
IDEXX Laboratories, Inc. $53.62 B
Lonza Group Ltd $47.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Natera, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $31.91 B 40.68%
Jan. 1, 2025 $22.68 B 216.29%
Jan. 1, 2024 $7.17 B 69.70%
Jan. 1, 2023 $4.23 B -47.73%
Jan. 1, 2022 $8.08 B -33.75%
Jan. 1, 2021 $12.20 B 204.60%
Jan. 1, 2020 $4.01 B 157.62%
Jan. 1, 2019 $1.56 B 30.55%
Jan. 1, 2018 $1.19 B 16.18%
Jan. 1, 2017 $1.03 B 4.80%
Jan. 1, 2016 $978.4 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Natera, Inc. Categories

United States languages Healthcare languages Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Stocks & Indices

Natera, Inc. has the following listings and related stock indices.


Stock: NASDAQ: NTRA

Stock: FSX: 45E

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.